254 Insulin-like growth factor 2 mRNA binding protein (IGF2BP1) regulates a set of target genes important in basal cell carcinoma development

نویسندگان

چکیده

Dysregulation of the Hedgehog (Hh) signaling pathway is implicated in development many cancers including BCC. PTCH1 and SMO are critical players Hh GLI1 transcriptional activator through which mediated. Mutation or have been shown to constitutively activate pathway. Active canonical Wnt has also be required for pathway–driven We previously identified a novel mechanism by regulates outcome signaling. show that IGF2BP1, direct target could bind Gli1 mRNA upregulate its expression. This regulation IGF2BP1 was independent upstream signal. hypothesized Wnt-dependent induction genes contribute BCC development. propose inhibition will reduce expression activity as well targets therefore prevent To test this, we generated skin specific knockout mouse model Ptch1tm1Mps/J background using Cre/loxp system. inhibited tamoxifen injection (75mg /kg) five consecutive days. Mice were subsequently exposed UVB irradiation (240 mJ/cm2) three times week 44 weeks. analyzed tumors developed control experimental mice observed significantly reduced lesions (P<0.05). The Gli2 same samples However, Ptch1 not affected inhibition. targets, c-myc βTrCP1 went might upregulating only Gli1, but additional promote progression disease.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Insulin-like growth factor-binding protein-2 is a target for the immunomodulation of breast cancer.

Breast cancer is immunogenic and well suited to treatment via immunomodulation. The disease is often treated to remission and time to relapse is generally measured in years in many cases. Immune-based therapeutics, such as cancer vaccines, may be able to affect the clinical progression of micrometastatic disease. Immune targets must be identified that have the potential to inhibit tumor growth....

متن کامل

MicroRNA-140-5p targets insulin like growth factor 2 mRNA binding protein 1 (IGF2BP1) to suppress cervical cancer growth and metastasis

MicroRNAs (miRNAs) are a class of small non-coding RNA molecules that play important roles in carcinogenesis and tumor progression. Previous studies have revealed that MicroRNA-140-5p (miR-140-5p) was abnormally expressed in several cancers. However, its function and possible mechanism in cervical cancer (CC) remains unknown. In this study, the data mining results showed that miR-140-5p was dow...

متن کامل

Insulin-like growth factor binding protein-2 is a novel therapeutic target associated with breast cancer.

PURPOSE Insulin-like growth factor (IGF) binding proteins (IGFBP) modulate interactions of IGF ligands with the IGF-I receptor. The role of IGFBPs, and specifically IGFBP-2, in breast cancer progression has been poorly defined. This study assesses the effect of IGFBP-2 on the behavior of human breast cancer using clinical specimens as well as in vitro and in vivo experimental systems. EXPERIM...

متن کامل

Clinical implications of insulin-like growth factor II mRNA-binding protein 3 expression in non-small cell lung carcinoma

In order to examine the role of insulin-like growth factor II mRNA-binding protein 3 (IMP3) expression for the prognostic evaluation of non-small cell lung carcinoma (NSCLC), a total of 186 breast cancer patients, with adjacent non-tumor lung tissues, were selected for immunohistochemical staining of IMP3 protein. The NSCLC tissues and paired adjacent non-tumor tissues of six patients were quan...

متن کامل

Insulin-like growth factor II mRNA-binding protein 3: a novel prognostic biomarker for oral squamous cell carcinoma.

BACKGROUND Oral squamous cell carcinoma (OSCC) is caused by multiple factors, including carcinogen exposure. Insulin-like growth factor II mRNA-binding protein 3 (IMP3) is highly expressed in various cancer cells but is rarely expressed in normal cells. We investigated whether IMP3 can be used as a prognostic biomarker for OSCC. METHODS We performed immunohistochemistry and Western blotting t...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of Investigative Dermatology

سال: 2023

ISSN: ['1523-1747', '0022-202X']

DOI: https://doi.org/10.1016/j.jid.2023.03.258